5 Interstitial Lung Disease Clinical Trials in Providence, RI (2026)

Q: How do I join a clinical trial in Providence?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you.

Recruiting Interstitial Lung Disease Studies in Providence

NCT06370520Recruiting

Screening Emotions in Adolescents at the Hospital for mTBI

The goal of this observational study is to develop and validate a clinical tool to predict which adolescents aged 11 to less than 18 years of age with mild traumatic brain injury (mTBI) are at an incr...

Providence, RI2,592 participantsUniversity of California, Davis

View Study Details

NCT05420766Recruiting

Impact of Sleep Duration on Immune Balance in Urban Children With Asthma

Urban children with asthma are at high risk for short sleep, due to an environment that jeopardizes both sleep and asthma management. Further, urban children with asthma suffer from altered immune bal...

Providence, RI204 participantsRhode Island Hospital

View Study Details

NCT06319027Recruiting

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

This phase II trial studies whether different imaging techniques can provide additional and more accurate information than the usual approach for assessing the activity of tumors in patients with newl...

Providence, RI100 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT06769282Recruiting

Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services

The goal of this clinical trial is to learn if this intervention (Social Skills, Problem Solving, emotion Regulation, and psycho-Education on Trauma: A Trauma-Informed Peer Aggression and Teen Dating ...

Providence, RI88 participantsRhode Island Hospital

View Study Details

NCT05879367Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

The purpose of this study is to establish the recommended phase 2 dose of eflornithine in combination with temozolomide in patients whose glioblastoma or astrocytoma is newly diagnosed, and to evaluat...

Providence, RI66 participantsOrbus Therapeutics, Inc.

View Study Details

About Interstitial Lung Disease Clinical Trials in Providence

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 5 interstitial lung disease clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 3,050 participants. Research is being sponsored by University of California, Davis, Rhode Island Hospital, ECOG-ACRIN Cancer Research Group and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Providence — FAQ

Are there interstitial lung disease clinical trials in Providence?

Yes, there are 5 interstitial lung disease clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 5 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 14, 2026 from ClinicalTrials.gov